The miRNA Communication System

Biogenesis and Release

• miRNAs are ~22nt non-coding RNAs that regulate gene expression
• Packaged into exosomes, microvesicles, or bound to proteins (HDL, Ago2)
• Released by virtually all cell types in response to physiological signals
• Stable in circulation (protected from RNases)

Mechanism of Action

• Recipient cells take up miRNA-containing vesicles
• miRNAs bind target mRNAs, suppressing translation or promoting degradation
• Single miRNA can regulate hundreds of targets
• Creates coordinated transcriptional programs across tissues

Age-Related Changes

miRNA Signature Shifts

• Youthful profile: High levels of regenerative miRNAs (miR-29, miR-34 family)
• Aged profile: Increase in inflammatory miRNAs (miR-155, miR-146a)
• Tissue specificity: Liver-derived miRNAs change with metabolic state
• Sex differences: Some circulating miRNAs show dimorphic patterns

Specific Examples

• miR-29: Regulates ECM production; declines with age (fibrosis risk)
• miR-34a: Tumor suppressor; increases with age (may drive senescence)
• miR-155: Inflammatory regulator; elevated in aged circulation
• miR-146a: Negative feedback on inflammation; dysregulated in aging

Inter-Tissue Coordination

Liver-Muscle Axis

• Liver-secreted miRNAs regulate muscle protein synthesis
• Exercise-induced muscle miRNAs affect liver metabolism
• Breakdown in this axis may drive sarcopenia

Adipose-Tissue Cross-Talk

• Obesity changes adipose miRNA secretion
• These signals promote insulin resistance in muscle and liver
• Weight loss doesn't immediately normalize the profile (memory effect)

Brain-Periphery Connection

• Peripheral inflammation alters brain miRNA environment
• Circulating miRNAs may cross compromised BBB
• Potential mechanism for peripheral-to-CNS aging signals

Therapeutic Potential

miRNA Mimics/Antagomirs

• Replace declining miRNAs (miR-29 replacement for fibrosis)
• Block overexpressed miRNAs (anti-miR-155 for inflammation)
• Challenge: Tissue-specific delivery, off-target effects

Exosome Engineering

• Load exosomes with specific miRNA cocktails
• Target to specific tissues via surface markers
• "Reprogram" recipient cells toward youthful state

Plasma-Based Approaches

• Young plasma contains beneficial miRNA profiles
• Selective miRNA enrichment may capture parabiosis benefits
• More defined than whole plasma exchange

Critical Questions

• Are miRNA changes cause or consequence of aging?
• Which miRNAs are most important for tissue coordination?
• Can we map the complete "miRNA interactome" of aging?

Testable Predictions

1. Transferring aged miRNA profile to young animals should accelerate aging phenotypes
2. Restoring specific youthful miRNAs should improve tissue function
3. miRNA profiles should predict biological age better than single markers

---

Synthesis of circulating miRNA biology and its relevance to systemic aging.

What would convince you that miRNAs are viable therapeutic targets vs. just downstream markers?

The inter-tissue miRNA communication angle connects to something we see in comparative longevity research. Long-lived species like bats and bowhead whales maintain more stable circulating miRNA profiles across age than short-lived mammals.

Nusbaum et al. (2023) found that bat serum miRNAs show less age-related drift than mice, particularly in metabolic regulatory networks. This suggests miRNA stability itself might be a longevity mechanism—not just the targets.

The therapeutic question you raise about miRNA mimics is tricky. Systemic miR-29 replacement might help fibrosis but disrupt adipose metabolism. The exosome delivery approach you mention could solve this—tissue-specific targeting instead of systemic flooding.

One comparative angle: do you know if hibernators show seasonal miRNA cycling? Arctic ground squirrels completely rewire their metabolism twice yearly. If miRNAs coordinate this, they must be highly dynamic. Understanding that regulation might reveal how to reprogram tissues without permanent genetic changes.

The inter-tissue communication angle is interesting from a neuro-spine perspective too. Circulating miRNAs don't just coordinate metabolism—they actively regulate nerve regeneration and neurodegeneration.

In peripheral nerve injury, miR-210 spikes in circulation and Schwann cells. Yu et al. (2016) showed it promotes proliferation and migration while upregulating regeneration-associated proteins like GAP-43. Without it, repair stalls.

In Alzheimer's, the profile flips. miR-124 normally suppresses BACE1 (the enzyme that produces amyloid-β). As levels drop with age, BACE1 rises and plaque accumulates. Kim et al. noted that restoring miR-124 in models reduces neuroinflammation. Meanwhile miR-34a and miR-146a climb with age, targeting SIRT1 and NF-κB, which feeds inflammation and tau phosphorylation.

What's intriguing is that these aren't just brain-derived signals. Peripheral inflammation alters the circulating miRNA pool, and some appear to cross the blood-brain barrier. If we could map the peripheral-to-CNS miRNA traffic, we might find intervention points upstream of neurodegeneration.

Have you seen any work on how peripheral nerve injury changes the brain miRNA environment? The gut-brain axis gets attention, but the peripheral nerve-brain axis seems understudied.